Purchase Order SPE2DP24P0665

Award Date 7/29/24
Potential Completion Date 9/27/24
Potential Value $1.8K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is for the supply of anticoagulant citrate, a specialized medical product used in blood collection, separation, storage, and transfusion. The contract has a ceiling value of $1,431.36 and an ultimate completion date of November 25, 2019. Fenwal, Inc. is a registered vendor with...
This firm-fixed-price purchase order was awarded by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi, for the supply of anticoagulant citrate. The $1,454.88 contract has an ultimate completion date of October 1, 2024 and does not have a set-aside designation. Fenwal is a global blood technology company specializing in products and services for blood collection, separation, storage, and transfusion. The company has a long history of providing a...
This is a $1,145.10 firm fixed-price purchase order contract awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Fenwal, Inc., a subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is for the supply of anticoagulant citrate products, which are critical medical consumables supporting healthcare and biomedical research initiatives, including military medical supply chains. Fenwal, Inc. is a registered federal vendor that has...
This federal contract award, valued at $1,839.04, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of blood packs with anticoagulant (8510030842) and has a completion date of August 14, 2023. Fenwal, a registered federal vendor since 2007, has a strong track record of supporting the U.S. government's healthcare and research initiatives by providing a diverse array...
Fenwal, Inc. has been awarded a $1,228.92 firm fixed price purchase order by the Defense Logistics Agency Troop Support Medical to deliver anticoagulant citra. The contract has no set-aside designation and calls for performance at Fenwal's Lake Zurich, Illinois facility by September 28, 2015. As a global blood technology company and manufacturer, Fenwal routinely supports the Department of Defense and other federal agencies through contracts to provide blood collection, storage, and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract, valued at $41,848.64, is for the delivery of blood packs with anticoagulants to support the agency's medical supply chain operations. Fenwal, Inc. is a registered federal vendor that has consistently secured contracts from various agencies, including the DLA, National...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is for the supply of blood pack units with anticoagulant, with a ceiling value of $1,101.28 and a completion date of June 30, 2025. Fenwal, Inc. is a global blood technology company and a registered vendor with the U.S. federal government, providing specialized medical equipment and consumables to support...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The contract is for the supply of a blood pack with an anticoagulant, with a ceiling value of $1,101.28 and an ultimate completion date of August 4, 2025. The contract does not have a set-aside designation. Fenwal, Inc. is a registered vendor with the U.S. federal government,...
This federal contract award, valued at $18,378.40, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of various blood collection supplies, including blood collection assemblies, washing solutions, diluting solutions, anticoagulant citrate products, donor tubing strippers, plasma extractors, blood pack sealers, and centrifuging bags. The contract has an ultimate completion date...

This is a federal contract award (SPE2DP24P0665) from the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Fenwal, Inc., a subsidiary of Fresenius Kabi. The $1,818.60 firm fixed price purchase order is for the supply of ANTICOAGULANT CITRA products, with a period of performance ending on September 27, 2024. Fenwal, a global blood technology company, has established itself as a key supplier to various federal agencies, including the Department of Defense, Department of Veterans Affairs, and National Institutes of Health, providing a diverse array of products and services to support critical healthcare and research initiatives. This contract award does not have a set-aside designation.

Generated 10/28/24, 9:46 AM